Francesca Crisafulli
Overview
Explore the profile of Francesca Crisafulli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vitale A, Caggiano V, Leone F, Hinojosa-Azaola A, Martin-Nares E, Guaracha-Basanez G, et al.
Front Pharmacol
. 2025 Mar;
16:1462254.
PMID: 40046741
Background: VEXAS syndrome, a recently identified systemic autoinflammatory disorder, poses new diagnostic and management challenges. Based on experience with other autoinflammatory diseases, anti-interleukin (IL)-1, anti-IL-6, anti-tumor necrosis factor (TNF) biotechnological...
2.
Crotti C, Ughi N, Beretta E, Brucato A, Carrara G, Chimenti M, et al.
Reumatismo
. 2025 Feb;
77(1).
PMID: 39945362
Objective: To date, there is no shared national guideline in Italy for the management of reproductive health in rheumatic diseases (RHRD). The Italian Society for Rheumatology (SIR) has committed to...
3.
Crisafulli F, Lazzaroni M, Nalli C, Orabona R, Franceschini F, Tincani A
J Clin Rheumatol
. 2024 Sep;
30(7S Suppl 1):S49-S55.
PMID: 39325125
Women with systemic chronic inflammatory disease, such as those with scleroderma, systemic vasculitis, and Sjögren syndrome, need preconception evaluation by a multidisciplinary team. Counseling and pregnancy management should be tailored...
4.
Sota J, Guerriero S, Lopalco G, Tufan A, Ragab G, AlMaglouth I, et al.
Ocul Immunol Inflamm
. 2024 May;
33(1):48-55.
PMID: 38759215
Purpose: The clinical relevance of human leukocyte antigen (HLA) subtypes such as HLA-B51 on Behçet's disease (BD)-related uveitis and non-infectious uveitis (NIU) unrelated to BD remains largely unknown. Methods: Data...
5.
Andreoli L, Gerardi M, Gerosa M, Rozza D, Crisafulli F, Erra R, et al.
RMD Open
. 2024 Apr;
10(2).
PMID: 38663885
Objectives: To investigate pregnancy outcomes in women with autoimmune rheumatic diseases (ARD) in the Italian prospective cohort study P-RHEUM.it. Methods: Pregnant women with different ARD were enrolled for up to...
6.
Vitale A, Caggiano V, Martin-Nares E, Frassi M, Dagna L, Hissaria P, et al.
Semin Arthritis Rheum
. 2024 Mar;
66:152430.
PMID: 38554594
VEXAS syndrome is a recently described monogenic autoinflammatory disease capable of manifesting itself with a wide array of organs and tissues involvement. Orbital/ocular inflammatory manifestations are frequently described in VEXAS...
7.
Andreoli L, Regola F, Caproli A, Crisafulli F, Fredi M, Lazzaroni M, et al.
Rheumatology (Oxford)
. 2024 Feb;
63(SI):SI86-SI95.
PMID: 38320595
This review focuses on the management of reproductive issues in women who have antiphospholipid syndrome (APS) or are carriers of antiphospholipid antibodies (aPL). The importance of aPL detection during preconception...
8.
Vitale A, Caggiano V, Sfikakis P, Dagna L, Lopalco G, Ragab G, et al.
Front Med (Lausanne)
. 2023 Dec;
10:1256243.
PMID: 38148914
Introduction: The effectiveness of canakinumab may change according to the different times it is used after Still's disease onset. This study aimed to investigate whether canakinumab (CAN) shows differences in...
9.
Gurnari C, Pascale M, Vitale A, Diral E, Tomelleri A, Galossi E, et al.
Am J Hematol
. 2023 Dec;
99(2):254-262.
PMID: 38108611
VEXAS is a prototypic hemato-inflammatory disease combining rheumatologic and hematologic disorders in a molecularly defined nosological entity. In this nationwide study, we aimed at screenshotting the current diagnostic capabilities and...
10.
Radin M, Cecchi I, Crisafulli F, Klumb E, Ramires de Jesus G, Lacerda M, et al.
Autoimmun Rev
. 2023 Oct;
22(12):103467.
PMID: 37852515
Background: Complement levels have been proposed as candidate biomarkers of disease activity and obstetric risk in systemic lupus erythematosus (SLE) pregnancies, but their reliability has been questioned due to the...